Basic principles

Pharmacokinetics in Drug Discovery and Development

Volumn , Issue , 2002, Pages 3-30

  Schoenwald, Ronald D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73349113575     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (36)

1. Teorell, T., Kinetics of distribution of substances administered to the body I. The extravascular modes of administration, Arch. Int. Pharmacodyn., 57: 205-225, 1937.
2. Teorell, T., Kinetics of distribution of substances administered to the body II. The intravascular modes of administration, Arch. Int. Pharmacodyn., 57: 226-240, 1937.
3. Wagner, J. G., Fundamentals of Clinical Pharmacokinetics, Drug Intelligence Publications, Inc., Hamilton, IL, 1975, 57-120.
4. Shargel, L. and Yu, A. B. C., Applied Biopharmaceutics and Pharmacokinetics, 4th ed., Appleton & Lange, Stamford, CT, 1999, 36-40.
5. Rowland, M. and Tozer, T. N., Clinical Pharmacokinetics Concepts and Applications, 3rd ed., Williams & Wilkins, Baltimore, MD, 1995, 313-322.
6. Bauer, L. A., Clinical pharmacokinetics and pharmacodynamics, in Pharmacotherapy a Physiological Approach, 4th ed., Dipiro, J. T. et al., Eds., Appleton & Lange, Stamford, CT, 1999, 21-43.
7. Gibaldi, M. and Perrier, D., Pharmacokinetics, Marcel Dekker, New York, 1975, 45-96.
8. Riggs, D. S., The Mathematical Approach to Physiological Problems, Williams & Wilkins, Baltimore, MD, 1963, 193-217.
9. Rowland, M. and Tozer, T. N., Clinical Pharmacokinetics Concepts and Applications, 3rd ed., Williams & Wilkins, Baltimore, MD, 1995, 18-19.
10. Rowland, M., Benet, L. Z., and Graham, G. G., Clearance concepts in pharmacokinetics, J. Pharmacokinet. Biopharm., 1: 123-136, 1973.
11. Gibaldi, M. and Perrier, D., Pharmacokinetics, Marcel Dekker, New York, 1975, 80-84.
12. Wagner, J. G. and Nelson, E., Percent absorbed time plots derived from blood level and/or urinary excretion data, J. Pharm. Sci., 52: 610-611, 1963.
13. Wagner, J. G., Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation, J. Pharm. Sci., 72: 838-842, 1983.
14. Loo, J. and Riegelman, S., New method for calculating the intrinsic absorption rate of drugs, J. Pharm. Sci., 57: 918-928, 1968.
15. Wagner, J. G., Pharmacokinetics for the Pharmaceutical Scientist, Technomic Publishing Co., Lancaster, PA, 1993, 159-205.
16. Gibaldi, M. and Perrier, D., Pharmacokinetics, Marcel Dekker, New York, 1975, 129-145.
17. Shargel, L. and Yu, A. B. C., Applied Biopharmaceutics and Pharmacokinetics, 4th ed., Appleton & Lange, Stamford, CT, 1999, 247-279.
18. Rowland, M. and Tozer, T. N., Clinical Pharmacokinetics Concepts and Applications, 3rd ed., Williams & Wilkins, Baltimore, MD, 1995, 34-46.
19. Wagner, J. G., Pharmacokinetics for the Pharmaceutical Scientist, Technomic Publishing Co., Lancaster, PA, 1993, 103-109.
20. Gibaldi, M. and Perrier, D., Pharmacokinetics, Marcel Dekker, New York, 1975, 97-128.
21. Gibaldi, M. and Perrier, D., Pharmacokinetics, 2nd ed., Marcel Dekker, New York, 1982, 121-123.
22. Schumacher, G. E., Therapeutic Drug Monitoring, Appleton & Lange, Norwalk, CT, 1995.
23. Wagner, J. G., Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, IL, 1971, 222-233.
24. Shargel, L. and Yu, A. B. C., Applied Biopharmaceutics and Pharmacokinetics, 4th ed., Appleton & Lange, Stamford, CT, 1999, 531-571.
25. Cockcroft, D. W. and Gault, M. H., Prediction of creatinine clearance from serum creatinine, Nephron, 16: 31-41, 1976.
26. Matzke, G. R. and Millikin, S. P., Influence of renal function and dialysis on drug disposition, in Applied Pharmacokinetics, Principles of Therapeutic Drug Monitoring, 3rd ed., Evans, W. E., Schentag. J. J., and Jusko, W. J., Eds., Applied Therapeutics, Vancouver, WA, 1992, 8: 18-8: 19.
27. Dettli, L., Elimination Kinetics and Dosage Adjustment of Drugs in Patients with Kidney Disease, Vol. 1, No. 4., Gustav Fischer Verlag, Stuttgart, Germany, 1977, 25-31.
28. Gibaldi, M., Biopharmaceutics and Clinical Pharmacokinetics, 4th ed., Lea & Febiger, Philadelphia, PA, 1991, 284-288.
29. Ludden, T. M. et al., Individualization of phenytoin dosage regimens, Clin. Pharmacol. Ther., 21: 287-293, 1977.
30. Tozer, T. N. and Winter, M. E., Phenytoin, in Applied Pharmacokinetics, Principles of Therapeutic Drug Monitoring, 3rd ed., Evans, W. E., Schentag, J.J., and Jusko, W.J., Eds., Applied Therapeutics, Vancouver, WA, 1992, 25: 1-25: 44.
31. Sheiner, L. B. et al., Forecasting individual pharmacokinetics, Clin. Pharmacol. Ther., 26: 294-305, 1979.
32. Vozeh, S. et al., Predicting individual phenytoin dosage regimens, J. Pharmacokinet. Biopharm., 9: 131-146, 1991.
33. Sheiner, L. B. and Beal, S. L., Bayesian individualization of pharmacokinetics -simple implementation and comparison with non-Bayesian methods, J. Pharm. Sci., 71: 1344-1348, 1982.
34. Martin, E. et al., The clinical pharmacokinetics of phenytoin, J. Pharmacokinet. Biopharm., 5: 579-596, 1977.
35. Yuen, G. J. et al., Predicting phenytoin dosages using Bayesian feedback: a comparison with other methods, Ther. Drug Monit., 5: 437-441, 1983.
36. Sheiner, L. B. and Beal, S. L., Evaluation of methods for estimating population pharmacokinetics parameters, I. Michaelis-Menten model: routine clinical pharmacokinetic pharmacokinetic data, J. Pharmacokinet. Biopharm., 8: 553-571, 1980.